Lerebours F - Search Results

1

A refined molecular taxonomy of breast cancer.

Guedj M, Marisa L, de Reynies A, Orsetti B, Schiappa R, Bibeau F, MacGrogan G, Lerebours F, Finetti P, Longy M, Bertheau P, Bertrand F, Bonnet F, Martin AL, Feugeas JP, Bièche I, Lehmann-Che J, Lidereau R, Birnbaum D, Bertucci F, de Thé H, Theillet C. Guedj M, et al. Among authors: lerebours f. Oncogene. 2012 Mar 1;31(9):1196-206. doi: 10.1038/onc.2011.301. Epub 2011 Jul 25. Oncogene. 2012. PMID: 21785460 Free PMC article.

2

[Rectal toxicity of Veganine suppositories: an unusual presentation].

Legallicier B, Parent B, Chamoun S, Duparc F, Lemoine F, Lerebours F, Colin R. Legallicier B, et al. Among authors: lerebours f. Gastroenterol Clin Biol. 1991;15(1):92-3. Gastroenterol Clin Biol. 1991. PMID: 2010078 French. No abstract available.

3

Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023.

Gligorov J, Benderra MA, Barthere X, de Forceville L, Antoine EC, Cottu PH, Delaloge S, Pierga JY, Belkacemi Y, Houvenaegel G, Pujol P, Rivera S, Spielmann M, Penault-Llorca F, Namer M; et l'ensemble des experts des votes des RPC Saint-Paul 2022-2023. Gligorov J, et al. Bull Cancer. 2023 Nov;110(10S):10S1-10S43. doi: 10.1016/S0007-4551(23)00473-3. Bull Cancer. 2023. PMID: 38061827

4

[Tissue microdissection: application to the study of cancer of the breast].

Bertheau P, de Thé H, de Roquancourt A, Lerebours F, Espié M, Janin A. Bertheau P, et al. Among authors: lerebours f. Ann Pathol. 1999;19(5 Suppl):S3-6. Ann Pathol. 1999. PMID: 10599450 French. No abstract available.

5

Allelic loss detection in inflammatory breast cancer: improvement with laser microdissection.

Bertheau P, Plassa LF, Lerebours F, de Roquancourt A, Turpin E, Lidereau R, de Thé H, Janin A. Bertheau P, et al. Among authors: lerebours f. Lab Invest. 2001 Oct;81(10):1397-402. doi: 10.1038/labinvest.3780353. Lab Invest. 2001. PMID: 11598152 Free article.

6

ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinoma.

Bièche I, Onody P, Lerebours F, Tozlu S, Hacene K, Andrieu C, Vidaud M, Tubiana-Hulin M, Spyratos F, Lidereau R. Bièche I, et al. Among authors: lerebours f. Cancer Lett. 2001 Dec 28;174(2):173-8. doi: 10.1016/s0304-3835(01)00696-6. Cancer Lett. 2001. PMID: 11689293

7

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy.

Bertheau P, Plassa F, Espié M, Turpin E, de Roquancourt A, Marty M, Lerebours F, Beuzard Y, Janin A, de Thé H. Bertheau P, et al. Among authors: lerebours f. Lancet. 2002 Sep 14;360(9336):852-4. doi: 10.1016/S0140-6736(02)09969-5. Lancet. 2002. PMID: 12243922

8

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer.

Turpin E, Bièche I, Bertheau P, Plassa LF, Lerebours F, de Roquancourt A, Olivi M, Espié M, Marty M, Lidereau R, Vidaud M, de Thé H. Turpin E, et al. Among authors: lerebours f. Oncogene. 2002 Oct 24;21(49):7593-7. doi: 10.1038/sj.onc.1205932. Oncogene. 2002. PMID: 12386822

9

Molecular alterations in sporadic breast cancer.

Lerebours F, Lidereau R. Lerebours F, et al. Crit Rev Oncol Hematol. 2002 Nov;44(2):121-41. doi: 10.1016/s1040-8428(01)00191-3. Crit Rev Oncol Hematol. 2002. PMID: 12413631 Review.

10

Evidence of chromosome regions and gene involvement in inflammatory breast cancer.

Lerebours F, Bertheau P, Bieche I, Driouch K, De The H, Hacene K, Espie M, Marty M, Lidereau R. Lerebours F, et al. Int J Cancer. 2002 Dec 20;102(6):618-22. doi: 10.1002/ijc.10729. Int J Cancer. 2002. PMID: 12448004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters